Andrew Dellinger

1.3k total citations
27 papers, 935 citations indexed

About

Andrew Dellinger is a scholar working on Epidemiology, Pharmacology and Molecular Biology. According to data from OpenAlex, Andrew Dellinger has authored 27 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 9 papers in Pharmacology and 7 papers in Molecular Biology. Recurrent topics in Andrew Dellinger's work include Drug-Induced Hepatotoxicity and Protection (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Diet, Metabolism, and Disease (5 papers). Andrew Dellinger is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (9 papers), Liver Disease Diagnosis and Treatment (8 papers) and Diet, Metabolism, and Disease (5 papers). Andrew Dellinger collaborates with scholars based in United States, United Kingdom and Hong Kong. Andrew Dellinger's co-authors include Michael A. Hauser, Herbert Pang, Allison E. Ashley‐Koch, Manal F. Abdelmalek, Ayako Suzuki, Anna Mae Diehl, Hans L. Tillmann, Cynthia A. Moylan, Susan K. Murphy and Melanie E. Garrett and has published in prestigious journals such as Nucleic Acids Research, Gastroenterology and Hepatology.

In The Last Decade

Andrew Dellinger

26 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Dellinger United States 12 490 349 168 165 130 27 935
Kimberly Viker United States 13 568 1.2× 217 0.6× 192 1.1× 254 1.5× 168 1.3× 18 915
Hiroto Kumemura Japan 15 454 0.9× 392 1.1× 436 2.6× 86 0.5× 146 1.1× 21 1.1k
Sylvie Goulinet France 11 414 0.8× 304 0.9× 443 2.6× 190 1.2× 65 0.5× 17 1.1k
Oihane García‐Irigoyen Spain 15 304 0.6× 455 1.3× 295 1.8× 34 0.2× 86 0.7× 21 989
Bedair Dewidar Germany 8 764 1.6× 420 1.2× 689 4.1× 140 0.8× 117 0.9× 16 1.4k
David Fernández‐Ramos Spain 18 309 0.6× 717 2.1× 132 0.8× 82 0.5× 81 0.6× 31 1.1k
Sunhwa Kim South Korea 5 489 1.0× 547 1.6× 380 2.3× 81 0.5× 64 0.5× 10 1.5k
Soo‐Ho Choi United States 18 307 0.6× 419 1.2× 207 1.2× 34 0.2× 56 0.4× 36 1.1k
Nirupma Trehanpati India 19 518 1.1× 279 0.8× 443 2.6× 48 0.3× 43 0.3× 70 1.0k
Charles D. Calenda United States 9 335 0.7× 294 0.8× 129 0.8× 62 0.4× 71 0.5× 11 675

Countries citing papers authored by Andrew Dellinger

Since Specialization
Citations

This map shows the geographic impact of Andrew Dellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Dellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Dellinger more than expected).

Fields of papers citing papers by Andrew Dellinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Dellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Dellinger. The network helps show where Andrew Dellinger may publish in the future.

Co-authorship network of co-authors of Andrew Dellinger

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Dellinger. A scholar is included among the top collaborators of Andrew Dellinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Dellinger. Andrew Dellinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmad, Jawad, Andrew Dellinger, Paola Nicoletti, et al.. (2025). Clinical and HLA Associations of Fluoroquinolone-Induced Liver Injury: Results From the Drug-Induced Liver Injury Network. The American Journal of Gastroenterology. 121(1). 151–158. 2 indexed citations
2.
Bonkovsky, Herbert L., Marwan Ghabril, Paola Nicoletti, et al.. (2024). Drug‐induced liver injury (DILI) ascribed to non‐steroidal anti‐inflammatory drugs (NSAIDs) in the USA—Update with genetic correlations. Liver International. 44(6). 1409–1421. 5 indexed citations
3.
Venturini, Nicholas, Paola Nicoletti, Andrew Dellinger, et al.. (2024). Drug-Induced Liver Injury in Pregnancy. Obstetrics and Gynecology. 143(6). 819–823. 1 indexed citations
4.
Nicoletti, Paola, Andrew Dellinger, Yi‐Ju Li, et al.. (2023). HLA-B*53:01 Is a Significant Risk Factor of Liver Injury due to Phenytoin and Other Antiepileptic Drugs in African Americans. The American Journal of Gastroenterology. 119(1). 200–202. 5 indexed citations
5.
Barritt, A. Sidney, et al.. (2023). When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network. The American Journal of Gastroenterology. 118(12). 2301–2304. 4 indexed citations
6.
Chalasani, Naga, Yi‐Ju Li, Andrew Dellinger, et al.. (2022). Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury. Journal of Hepatology. 78(2). 293–300. 25 indexed citations
7.
Nicoletti, Paola, Andrew Dellinger, Yi‐Ju Li, et al.. (2022). Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate. Gastroenterology. 164(3). 454–466. 25 indexed citations
8.
Li, Yi‐Ju, Elizabeth J. Phillips, Andrew Dellinger, et al.. (2020). Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim‐Sulfamethoxazole Induced Liver Injury. Hepatology. 73(1). 268–281. 53 indexed citations
9.
Li, Yi‐Ju, Andrew Dellinger, Paola Nicoletti, et al.. (2019). FRI-079-HLA B*14:01 is associated with Trimethoprim-sulfamethoxazole induced liver injury. Journal of Hepatology. 70(1). e419–e419. 2 indexed citations
10.
Jia, Jingquan, Andrew Dellinger, Eric S. Weiss, et al.. (2015). Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing. Clinical Cancer Research. 21(15). 3442–3452. 4 indexed citations
11.
Uronis, Hope E., Jingquan Jia, Johanna C. Bendell, et al.. (2014). A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 75(2). 343–352. 8 indexed citations
12.
Dellinger, Andrew, Andrew B. Nixon, & Herbert Pang. (2014). Integrative Pathway Analysis Using Graph-Based Learning with Applications to TCGA Colon and Ovarian Data. Cancer Informatics. 13s4(Suppl 4). CIN.S13634–CIN.S13634. 7 indexed citations
13.
Murphy, Susan K., Hyuna Yang, Cynthia A. Moylan, et al.. (2013). Relationship Between Methylome and Transcriptome in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 145(5). 1076–1087. 298 indexed citations
14.
Uronis, Hope E., Johanna C. Bendell, Gerard C. Blobe, et al.. (2013). A phase I study ofABT‐510 plus bevacizumab in advanced solid tumors. Cancer Medicine. 2(3). 316–324. 21 indexed citations
15.
Moylan, Cynthia A., Herbert Pang, Andrew Dellinger, et al.. (2013). Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease. Hepatology. 59(2). 471–482. 234 indexed citations
16.
Xu, Pu‐Ting, Sophie Thomas, Andrew Dellinger, et al.. (2012). Transcriptome profiling of genes involved in neural tube closure during human embryonic development using long serial analysis of gene expression (long‐SAGE). Birth Defects Research Part A Clinical and Molecular Teratology. 94(9). 683–692. 17 indexed citations
17.
Strickler, John H., Alexander Starodub, Jingquan Jia, et al.. (2012). Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors. Cancer Chemotherapy and Pharmacology. 70(2). 251–258. 36 indexed citations
18.
Liu, Yutao, David Layfield, Andrew Dellinger, et al.. (2011). Serial analysis of gene expression (SAGE) in normal human trabecular meshwork.. PubMed. 17. 885–93. 16 indexed citations
19.
Mei, Hao, Wei Chen, Andrew Dellinger, et al.. (2010). Principal-component-based multivariate regression for genetic association studies of metabolic syndrome components. BMC Genetics. 11(1). 100–100. 6 indexed citations
20.
Dellinger, Andrew, Seang‐Mei Saw, Liang Kee Goh, et al.. (2010). Comparative analyses of seven algorithms for copy number variant identification from single nucleotide polymorphism arrays. Nucleic Acids Research. 38(9). e105–e105. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly Viker Breakdown of academic impact, for papers by Hiroto Kumemura Breakdown of academic impact, for papers by Sylvie Goulinet Breakdown of academic impact, for papers by Oihane García‐Irigoyen Breakdown of academic impact, for papers by Bedair Dewidar Breakdown of academic impact, for papers by David Fernández‐Ramos Breakdown of academic impact, for papers by Sunhwa Kim Breakdown of academic impact, for papers by Soo‐Ho Choi Breakdown of academic impact, for papers by Nirupma Trehanpati Breakdown of academic impact, for papers by Charles D. Calenda
Rankless by CCL
2026